Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Koenecke

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|July 13, 2018
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative DiseaseRebecca E Schultze-Florey, Sabine Tischer, Leonie Kuhlmann, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood Advances|September 17, 2021
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLIChristian R Schultze-Florey, Leonie Kuhlmann, Solaiman Raha, et al.
Leukemia & Lymphoma|July 18, 2022
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trialStephanie Sasse, Paul Jan Bröckelmann, Jesko Momotow, et al.
The Journal of Experimental Medicine|July 19, 2022
A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DRMalte Deseke, Francesca Rampoldi, Inga Sandrock, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia|August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trialHeiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
Bone Marrow Transplantation|August 19, 2025
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working partyDrazen Pulanic, Christophe Peczynski, William Boreland, et al.
Hepatology Communications|September 17, 2021
The Detrimental Role of Regulatory T Cells in Nonalcoholic SteatohepatitisJanine Dywicki, Laura Elisa Buitrago-Molina, Fatih Noyan, et al.
Oncology Research and Treatment|January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in GermanyOlaf Penack, Peter Dreger, Salem Ajib, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|July 13, 2018
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative DiseaseRebecca E Schultze-Florey, Sabine Tischer, Leonie Kuhlmann, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood Advances|September 17, 2021
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLIChristian R Schultze-Florey, Leonie Kuhlmann, Solaiman Raha, et al.
Leukemia & Lymphoma|July 18, 2022
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trialStephanie Sasse, Paul Jan Bröckelmann, Jesko Momotow, et al.
The Journal of Experimental Medicine|July 19, 2022
A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DRMalte Deseke, Francesca Rampoldi, Inga Sandrock, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia|August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trialHeiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
Bone Marrow Transplantation|August 19, 2025
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working partyDrazen Pulanic, Christophe Peczynski, William Boreland, et al.
Hepatology Communications|September 17, 2021
The Detrimental Role of Regulatory T Cells in Nonalcoholic SteatohepatitisJanine Dywicki, Laura Elisa Buitrago-Molina, Fatih Noyan, et al.
Oncology Research and Treatment|January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in GermanyOlaf Penack, Peter Dreger, Salem Ajib, et al.
Pageof 11